These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21857072)

  • 1. Therapeutic potential of adenosine analogues and conjugates.
    Samsel M; Dzierzbicka K
    Pharmacol Rep; 2011; 63(3):601-17. PubMed ID: 21857072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.
    Rubino A; Ralevic V; Burnstock G
    Br J Pharmacol; 1995 Jun; 115(4):648-52. PubMed ID: 7582485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine receptor subtypes: characterization and therapeutic regulation.
    Olah ME; Stiles GL
    Annu Rev Pharmacol Toxicol; 1995; 35():581-606. PubMed ID: 7598508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
    Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L
    J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine receptor ligands-recent developments part I. Agonists.
    Muller CE
    Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ; Dickenson JM
    Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
    Prentice DJ; Hourani SM
    Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.
    Wanner MJ; Von Frijtag Drabbe Künzel JK; Ijzerman AP; Koomen GJ
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2141-4. PubMed ID: 10999489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular adenosine receptors; potential clinical applications.
    Ho MF; Rose'Meyer RB
    Curr Vasc Pharmacol; 2013 May; 11(3):327-37. PubMed ID: 22724462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.
    Linden J
    Annu Rev Pharmacol Toxicol; 2001; 41():775-87. PubMed ID: 11264476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?
    Antonioli L; Fornai M; Colucci R; Tuccori M; Blandizzi C
    Expert Opin Investig Drugs; 2011 Jun; 20(6):717-21. PubMed ID: 21506907
    [No Abstract]   [Full Text] [Related]  

  • 13. Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.
    Pflug A; Rogozina J; Lavogina D; Enkvist E; Uri A; Engh RA; Bossemeyer D
    J Mol Biol; 2010 Oct; 403(1):66-77. PubMed ID: 20732331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
    Takano H; Bolli R; Black RG; Kodani E; Tang XL; Yang Z; Bhattacharya S; Auchampach JA
    Circ Res; 2001 Mar; 88(5):520-8. PubMed ID: 11249876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxation of mouse isolated aorta to adenosine and its analogues does not involve adenosine A(1), A(2) or A(3) receptors.
    Prentice D; Boon K; Hourani S
    Eur J Pharmacol; 2001 Mar; 415(2-3):251-5. PubMed ID: 11275007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the ability of highly charged nanomolar inhibitors of protein kinases to cross plasma membranes and carry a protein into cells.
    Uri A; Raidaru G; Subbi J; Padari K; Pooga M
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2117-20. PubMed ID: 12127517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
    Jagtap PG; Chen Z; Szabó C; Klotz KN
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1495-8. PubMed ID: 15006389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CREB phosphorylation by conjugates of adenosine analogues and arginine-rich peptides, inhibitors of PKA catalytic subunit.
    Kriisa M; Sinijärv H; Vaasa A; Enkvist E; Kostenko S; Moens U; Uri A
    Chembiochem; 2015 Jan; 16(2):312-9. PubMed ID: 25487811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C.
    Hu K; Huang CS; Jan YN; Jan LY
    Neuron; 2003 May; 38(3):417-32. PubMed ID: 12741989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands.
    Lim MH; Kim HO; Moon HR; Lee SJ; Chun MW; Gao ZG; Melman N; Jacobson KA; Kim JH; Jeong LS
    Bioorg Med Chem Lett; 2003 Mar; 13(5):817-20. PubMed ID: 12617898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.